newsfilter
← Earnings
Earnings Releases·

DocGo — Third Quarter 2026 Earnings Summary

  • Q3 2026 revenue rose to $73.4 million from $70.8 million in Q3 2025, while GAAP gross margin expanded to 29.7% from 20.0% and net loss narrowed to $18.1 million from $29.7 million.
  • Full-year 2026 revenue guidance was revised down to approximately $300 million (from $305-$310 million) to reflect the elimination of unprofitable business lines, though adjusted EBITDA guidance remains unchanged at ($17-$22) million.
  • Management expects to exit the year at a profitable run rate driven by AI-driven cost optimizations and the planned exit of the upstate New York market, with the Hicuity Health acquisition on track to close in late November or early December 2026.
  • The Board has initiated a CEO search led by Heidrick & Struggles as current CEO Lee Bienstock's contract expires on December 31, 2026, though he will remain through at least March 31, 2027, to ensure continuity.
Company
DOCGO INC
Sector
Healthcare
Industry
Medical Care Facilities